home / stock / vyyrf / vyyrf news

VYYRF News and Press, Voyageur Minerals Ltd From 04/21/21

Stock Information
Company Name: Voyageur Minerals Ltd
Stock Symbol: VYYRF
Market: OTC
Website: voyageurpharmaceuticals.ca
Menu
VYYRF VYYRF Quote VYYRF Short VYYRF News VYYRF Articles VYYRF Message Board
Get VYYRF Alerts

News, Short Squeeze, Breakout and More Instantly...
VYYRF - InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals and Beneficial Ruling by the D.C. Circuit Court of Appeals Qualifying Voyageurs Products as Devices not Drugs - Video Available on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - April 21, 2021) - Voyageur Pharmaceuticals (TSXV: VM) (OTC Pink: VYYRF) announced that the D.C. Circuit Court of Appeals has upheld a prior ruling that concluded radiographic contrast agent barium sulfate qualifies as a device rather than a drug. ...
VYYRF - Recent Decision from DC Circuit Court Likely to Result in Less Cost and Faster Approvals for Voyageur Barium Products - Voyageur Hires Team of Experts to Support Product Roll-Out

(TheNewswire) Calgary, Alberta – TheNewswire - April 20, 2021 – Voyageur Pharmaceuticals Ltd. ( TSX.V : VM ) USA (OTC : VYYRF) (the “Company” or “Voyageur”), i...

VYYRF - Voyageur Pharmaceuticals Ltd. Announces up to $1,725,000 Private Placement Financing

(TheNewswire) Calgary, Alberta – TheNewswire - April 13 th 2021 – Voyageur Pharmaceuticals Ltd. ( TSXV : VM ) USA (OTC : VYYRF) (the “Company” or “Voyageur”...

VYYRF - InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' Two New License Approvals from Health Canada for its MultiX Barium Sulfate Powder Covering Oral and Rectal Applications - Video Available on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - April 7, 2021) -  Voyageur Pharmaceuticals (TSXV: VM) (OTC: VYYRF) has received two license approvals from Health Canada for its MultiX barium sulfate powder. The two licenses cover both oral and rectal applications. MultiX is specifically de...
VYYRF - Voyageur Pharmaceuticals Ltd. Announces Two Health Canada Approvals and Issuance of Product Licenses for MultiX Ba; Radiographic Barium Contrast

(TheNewswire) Calgary, Alberta - TheNewswire - April 5 th , 2021 - Voyageur Pharmaceuticals Ltd. ( TSX.V:VM) ( OTC :VYYRF ) (the "Company" or "Voyageur") is pleased to announce that it has received approval from Health Canada (HC...

VYYRF - Voyageur Pharmaceuticals Ltd. Signs Manufacturing Agreement With Alberta Veterinarian Laboratories Ltd. for Barium Radiographic Contrast Production

(TheNewswire) Calgary, Alberta – TheNewswire - March 22 nd , 2021 – Voyageur Pharmaceuticals Ltd. ( TSX.V : VM ) USA (OTC : VYYRF) (the "Company" or "Voyageur") announ...

VYYRF - Voyageur Pharmaceuticals Ltd. Receives $209,764.05 from Exercise of Warrants and Options

(TheNewswire) Calgary, Alberta - TheNewswire - March 10, 2021 - Voyageur Pharmaceuticals Ltd. ( TSXV : VM ) ( OTC : VYYRF) (the "Company" or "Voyageur") announces that it has received $ 209...
VYYRF - InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' Receipt of Approval from Health Canada for Two of the Company's Barium Contrast Products - Video Available on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - February 17, 2021) - Voyageur Pharmaceuticals (TSXV: VM) (OTCQB: VYYRF) has received approval from Health Canada for two of the company's barium contrast products. SmoothX, the company's barium radiographic contrast suspension specifically formul...

VYYRF - Voyageur Pharmaceuticals Ltd. Announces Second Health Canada Approval and Issuance of Product License for HDXBa; Radiographic Barium Contrast

(TheNewswire) Calgary, Alberta - TheNewswire - February 16, 2021 - Voyageur Pharmaceuticals Ltd. ( TSX V : VM ) ( OTC : VYYRF) (the "Company" or "Voyageur") is pleased to announce that it has r...

VYYRF - Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product License for SmoothX; Radiographic Barium Contrast Suspension

(TheNewswire) Calgary, Alberta – TheNewswire - February 12, 2021 – Voyageur Pharmaceuticals Ltd. ( TSXV : VM ) USA (OTC : VYYRF) (the "Company" or "Voyageur") is pleased to announce that ...
Previous 10 Next 10